Press Releases Press Releases Year None20222021202020192018 Date Title July 13, 2022 InVivo Therapeutics Announces Appointment of Heather M. Hamel as Chief Legal Officer and General Counsel June 8, 2022 InVivo Therapeutics Announces Publication of 12- and 24-month Data for INSPIRE 1.0 Study in Peer-Reviewed Neurosurgery June 2, 2022 InVivo Therapeutics Announces Completion of Enrollment for the INSPIRE 2.0 Acute Spinal Cord Injury Study April 14, 2022 InVivo Therapeutics Announces Reverse Stock Split January 6, 2022 InVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright BioConnect Conference Invivo - Investor Tools Print Page Email Alerts RSS Feeds Contact IR
Press Releases Year None20222021202020192018 Date Title July 13, 2022 InVivo Therapeutics Announces Appointment of Heather M. Hamel as Chief Legal Officer and General Counsel June 8, 2022 InVivo Therapeutics Announces Publication of 12- and 24-month Data for INSPIRE 1.0 Study in Peer-Reviewed Neurosurgery June 2, 2022 InVivo Therapeutics Announces Completion of Enrollment for the INSPIRE 2.0 Acute Spinal Cord Injury Study April 14, 2022 InVivo Therapeutics Announces Reverse Stock Split January 6, 2022 InVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright BioConnect Conference
